Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n‐of‐1 trial of weekly‐interval red cell transfusion in myelodysplastic syndromes

Documenti analoghi

• Red blood cell transfusion practice and cardiac comorbidities in patients with myelodysplastic syndromes
  di: Allison Mo, et al.
  Pubblicazione: (2025)
• Fatal posterior reversible encephalopathy syndrome after blood transfusion in a patient with myelodysplastic syndromes
  di: Ken Takigawa, et al.
  Pubblicazione: (2024)
• Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE
  di: Rena Buckstein, et al.
  Pubblicazione: (2024)
• Outcomes of massive transfusion recipients administered ABO‐incompatible fresh frozen plasma
  di: Joanna Bao‐Ern Loh, et al.
  Pubblicazione: (2024)
• When transfusion causes a splitting headache: A case report and rapid review of transfusion‐associated reversible cerebral vasoconstriction syndrome
  di: Bobbie Pelham‐Webb, et al.
  Pubblicazione: (2024)